Researchers at the Wolfson Molecular Imaging Centre and the Sir Peter Mansfield Imaging Centre have reported on a new utility of the PET tracer florbetapir. They found that the tracer can distinguish frontotemporal dementia (FTD) from Alzheimer’s disease and the cognitively normal elderly. {read more here}